Advertisement
Advertisement
U.S. markets open in 8 hours 34 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Cannara Biotech Inc. (LOVFF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.10180.0000 (0.00%)
At close: 11:56AM EST
Advertisement

Cannara Biotech Inc.

333 Decarie boulevard
Suite 200 St-Laurent
Montreal, QC H4N 3M9
Canada

https://cannara.ca

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Zohar KrivorotFounder, Pres, CEO & ChairmanN/AN/A1978
Mr. Nicholas Sosiak C.A., CPAChief Financial Officer163.68kN/AN/A
Avi KrivorotChief Technology Officer70.43kN/AN/A
Mr. Anthony ManoukVP Compliance & GMN/AN/AN/A
Mr. David AbitbolVP of MarketingN/AN/AN/A
Ms. Julia BouvetChief of StaffN/AN/AN/A
Alexander WolfeVP of Bus. Devel.N/AN/AN/A
Etienne LedouxExec. OfficerN/AN/AN/A
Brian ShermanVPN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-infused products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Montreal, Canada.

Corporate Governance

Cannara Biotech Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement